🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I work in an NHS Covid ward – and I feel so angry theguardian.com/world/2021/jul…

🎉We are 20 years old!🎉 Join us in celebrating two decades of research, reviews, commentaries, & more that have contributed to advancing our understanding of #InfectiousDiseases. Read our special anniversary issue: hubs.li/H0Tk22p0 #LancetInfDis20 #IDTwitter

New Correspondence: Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 thelancet.com/journals/lanin… #COVID19

New research Article: Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study thelancet.com/journals/lanin…

We are recruiting, for a full-time senior editor based in UK to organise peer review of research articles relx.wd3.myworkdayjobs.com/en-US/relx/job…. Follow the link to find out more.

Trying to function as an adult with a mental health condition 🤯

New joint review Series with our colleagues @EBioMedicine on Combating childhood infections in LMICs: evaluating the contribution of big data thelancet.com/series/big-dat…

He was boozing at that drinks party for twenty-five minutes. Please RT if you want him gone.

New news feature: The origin of #SARSCoV2 variants of concern thelancet.com/journals/lanin…

Still doesn’t feel real. Far too young with far too much left to do. He was a a fantastic mentor and friend. He saw in me potential I did not see in myself and he taught me so much. We are all so devastated by this loss.

Our April Issue is now live! Featuring articles covering COVID-19 related mortality in Chennai 🇮🇳, Bedaquiline-resistant #TB and testing a Typhoid vaccine in Nepal🇳🇵 thelancet.com/journals/lanin…

Our May Issue is now live! Featuring articles covering persistence of #vaccine 💉 protection against SARS-CoV-2 in Italy 🇮🇹 , #COVID related disruption on dengue 🦟transmission and immunogenicity and safety of a neonatal rotavirus vaccine in Malawi 🇲🇼 thelancet.com/journals/lanin…

New research: Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial thelancet.com/journals/lanin…

New research: Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study thelancet.com/journals/lanin…

Read our February issue! Featuring testing a dengue vaccine in Bangladesh, antimalarial resistance in South America, and a simplified schedule for rabies vaccination thelancet.com/journals/lanin…

Risk of death from #chikungunya continues for up to three months, new The Lancet Infectious Diseases research suggests Analysis of 150,000 records shows risk of complications from the #mosquito-borne virus persist even after acute infection subsides🦟 👉bit.ly/49dLxYK

Misinformation is not a new phenomenon – far from it. However, the COVID-19 pandemic highlighted how infodemics (an overabundance of information, including mis- and disinformation) pose a threat to health and confidence in research. Expand the thread ⤵️

Read our June issue! Featuring BCG vaccination in Brazilian health workers, dual-insecticide bednets for malaria control, and trial on dengue monoclonal antibody thelancet.com/journals/lanin…

Read our July issue! Featuring the global burden of tuberculosis, a candidate vaccine for hookworm infection, and listeria-associated peritonitis thelancet.com/journals/lanin…

Read our August issue! Featuring RSV prevention with nirsevimab, progress towards a Chlamydia vaccine and human challenge to assess dengue vaccines. thelancet.com/journals/lanin…